Melinda  Litherland net worth and biography

Melinda Litherland Biography and Net Worth

Melinda Litherland has served as a member of our board of directors since June 2021. Ms. Litherland currently serves on the board of directors of Bio-Rad Laboratories, Inc., where she has served since April 2017. Ms. Litherland retired in 2015 as a Partner at Deloitte & Touche LLP. During her 34 years at Deloitte & Touche LLP, she worked primarily with technology and life science companies in both audit and consulting capacities. Ms. Litherland holds a BA in Economics from Rice University and a Master of Accounting from the Rice University Jones Graduate School of Business. Ms. Litherland is a certified public accountant and a member of the American Institute of CPAs (AICPA). 

What is Melinda Litherland's net worth?

The estimated net worth of Melinda Litherland is at least $28.97 thousand as of December 3rd, 2024. Ms. Litherland owns 45,180 shares of Rapid Micro Biosystems stock worth more than $28,969 as of November 7th. This net worth evaluation does not reflect any other investments that Ms. Litherland may own. Learn More about Melinda Litherland's net worth.

How do I contact Melinda Litherland?

The corporate mailing address for Ms. Litherland and other Rapid Micro Biosystems executives is 25 Hartwell Avenue, Lexington, MA, 02421. Rapid Micro Biosystems can also be reached via phone at 978-349-3200 and via email at [email protected]. Learn More on Melinda Litherland's contact information.

Has Melinda Litherland been buying or selling shares of Rapid Micro Biosystems?

Melinda Litherland has not been actively trading shares of Rapid Micro Biosystems within the last three months. Most recently, on Thursday, December 5th, Melinda Litherland bought 9,120 shares of Rapid Micro Biosystems stock. The stock was acquired at an average cost of $1.04 per share, with a total value of $9,484.80. Following the completion of the transaction, the director now directly owns 54,300 shares of the company's stock, valued at $56,472. Learn More on Melinda Litherland's trading history.

Who are Rapid Micro Biosystems' active insiders?

Rapid Micro Biosystems' insider roster includes Melinda Litherland (Director), Robert Spignesi, Jr. (President and CEO), and Sean Wirtjes (CFO). Learn More on Rapid Micro Biosystems' active insiders.

Are insiders buying or selling shares of Rapid Micro Biosystems?

In the last twelve months, insiders at the sold shares 13 times. They sold a total of 249,705 shares worth more than $1,021,363.85. The most recent insider tranaction occured on March, 11th when COO John J Addington Wilson sold 9,603 shares worth more than $41,484.96. Insiders at Rapid Micro Biosystems own 12.7% of the company. Learn More about insider trades at Rapid Micro Biosystems.

Information on this page was last updated on 3/11/2026.

Melinda Litherland Insider Trading History at Rapid Micro Biosystems

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/5/2024Buy9,120$1.04$9,484.8054,300View SEC Filing Icon  
12/3/2024Buy10,880$1.00$10,880.0045,180View SEC Filing Icon  
11/26/2024Buy108$1.04$112.3214,408View SEC Filing Icon  
See Full Table

Melinda Litherland Buying and Selling Activity at Rapid Micro Biosystems

This chart shows Melinda Litherland's buying and selling at Rapid Micro Biosystems by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Rapid Micro Biosystems Company Overview

Rapid Micro Biosystems logo
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
Read More

Today's Range

Now: $0.64
Low: $0.58
High: $0.67

50 Day Range

MA: $0.99
Low: $0.62
High: $1.57

2 Week Range

Now: $0.64
Low: $0.58
High: $4.94

Volume

156,160 shs

Average Volume

147,797 shs

Market Capitalization

$32.16 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.52